Devonian Healthcare Group Reports its First ever Revenues: Key Financial Results for Quarter Ended April 30th, 2018
PRESS RELEASE For immediate release Devonian Healthcare Group Reports its First ever Revenues: Key Financial Results for Quarter Ended April 30th, 2018 Quebec, Quebec – July 18, 2018 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a...
Devonian Announces Grant of Options
PRESS RELEASE For immediate release Devonian Announces Grant of Options. Quebec, Quebec - June 29th, 2018 – Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXv: GSD) announces that the Board of Directors has approved the grant of options (the...
Devonian Announces the Signing of a Non-Binding Letter of Intent with Folia Biotech to develop FB-631 in cancer immunotherapy.
PRESS RELEASE For immediate release Devonian Announces the Signing of a Non-Binding Letter of Intent with Folia Biotech to develop FB-631 in cancer immunotherapy. Quebec, Quebec - June 28th, 2018 – Devonian Health Group Inc. ("Devonian" or the "Corporation")...
Devonian Health Group Announces issuance of United States Patent for its Purgenesis™ anti-aging treatment.
PRESS RELEASE For immediate release Devonian Health Group Announces issuance of United States Patent for its Purgenesis™ anti-aging treatment. Quebec, June 27th, 2018 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD)Devonian Health Group Inc....
Devonian Health Group announces the commercial launch of the Purgenesis™ Anti-aging treatment at the Canadian Dermatology Association’s annual conference
PRESS RELEASE For immediate release Devonian Health Group announces the commercial launch of the Purgenesis™ Anti-aging treatment at the Canadian Dermatology Association’s annual conference. First launch of the Purgenesis™ skin care line First and only product...
Purgenesis™: Commercializing a Skin-Care Revolution
READ MORE
Devonian Health Group Announces Canadian Patent for its Purgenesis™ anti-aging treatment
PRESS RELEASE For immediate release Devonian Health Group Announces Canadian Patent for its Purgenesis™ anti-aging treatment. Quebec - May 16th, 2018 – Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXv: GSD) today announced that the Canadian...
Devonian Announces Grant of Options
PRESS RELEASE For immediate release Devonian Announces Grant of Options. QUEBEC, Québec - March 21st, 2018 – Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXv: GSD) announces that the Board of Directors has approved the grant of options (the...
Devonian announces the trading of its shares will resume on Tuesday February 27th, 2018
PRESS RELEASE For immediate release Devonian announces the trading of its shares will resume on Tuesday February 27th, 2018 QUEBEC, February 23rd, 2018 – Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXv: GSD) is pleased to announce that it has...
Aspri Pharma Canada Inc. Announces Acquisition of Subordinate Voting Shares of Devonian Health Group Inc.
Source: Aspri Pharma Canada Inc. February 07, 2018 09:57 ET Amended News Release - Aspri Pharma Canada Inc. Announces Acquisition of Subordinate Voting Shares of Devonian Health Group Inc. CONCORD, Ontario, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Aspri Pharma Canada Inc....